Hualan Biological Vaccine Inc. (SHE:301207)
China flag China · Delayed Price · Currency is CNY
14.05
-0.15 (-1.06%)
Nov 17, 2026, 3:04 PM CST

Hualan Biological Vaccine Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
697.411,2031,1282,4101,8261,830
Revenue Growth
-28.58%6.62%-53.21%32.03%-0.23%-24.59%
Gross Profit
445.31877.36841.032,0281,4561,476
Operating Income
-57.9990.2794.64881.98504.09672.29
Net Income
46.16182.92205.52859.97519.63620.97
Earnings Per Share
0.080.310.341.430.881.15
EPS Growth
-34.38%-10.54%-75.93%62.20%-23.46%-32.86%

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Flu vaccine
1,1991,1232,4071,8181,825
Others
3.264.613.28.115.21
Total
1,2031,1282,4101,8261,830

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
3,2592,7853,2272,6132,149957.39
Total Debt
--300.18300.18300.18502.27
Net Cash (Debt)
3,2592,7852,9262,3131,849455.12
Net Cash Growth
5.95%-4.84%26.53%25.07%306.31%-31.59%
Net Cash Per Share
5.494.684.893.843.130.84

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
392.45357.13468.04888.02288.66569.33
Capital Expenditures
-20.53-9.7-51.6-62.6-92.65-636.06
Free Cash Flow
371.92347.43416.45825.42196.01-66.73
Free Cash Flow Growth
31.87%-16.57%-49.55%321.10%--

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
63.85%72.96%74.57%84.15%79.78%80.65%
Operating Margin
-8.32%7.51%8.39%36.59%27.61%36.74%
Pretax Margin
4.56%15.62%19.02%41.77%32.29%38.57%
Profit Margin
6.62%15.21%18.22%35.68%28.46%33.94%
FCF Margin
53.33%28.89%36.93%34.24%10.74%-3.65%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
1.6001.4000.2000.6000.2000.133
Dividend Per Share Growth
12.50%600.00%-66.67%200.00%50.04%-
Dividend Yield
11.39%7.51%1.14%2.16%0.67%-

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
180.7960.6050.6919.4034.32-
Forward PE
39.037.759.8615.2217.00-
P/FCF Ratio
22.4831.9125.0220.2190.98-
PS Ratio
11.999.229.246.929.77-